Mechanisms underlying age-related defects within lymphoid-lineages remain poorly understood. We previously reported that sex steroid ablation (SSA) induced lymphoid rejuvenation and enhanced recovery from hematopoietic stem cell (HSC) transplantation (HSCT). We herein show that, mechanistically, SSA induces hematopoietic and lymphoid recovery by functionally enhancing both HSC self-renewal and propensity for lymphoid differentiation through intrinsic molecular changes. Our transcriptome analysis revealed further hematopoietic support through rejuvenation of the bone marrow (BM) microenvironment, with upregulation of key hematopoietic factors and master regulatory factors associated with aging such as Foxo1. These studies provide important cellular and molecular insights into understanding how SSA-induced regeneration of the hematopoietic compartment can underpin recovery of the immune system following damaging cytoablative treatments. These findings support a short-term strategy for clinical use of SSA to enhance the production of lymphoid cells and HSC engraftment, leading to improved outcomes in adult patients undergoing HSCT and immune depletion in general.
INTRODUCTION
One key etiological factor underlying a wide range of diseases is the progressive decline in immune function with age (Dorshkind et al., 2009) . At its core is a reduction in lymphopoiesis within the bone marrow (BM) and thymus (Miller and Allman, 2003; Rodewald, 1998) , attributed in part to a decrease in the number and function of lymphoid progenitors (Min et al., 2004 (Min et al., , 2006 . Increasing evidence suggests that intrinsic changes to the earliest hematopoietic stem cells (HSCs) also contribute toward age-related immune degeneration (Geiger et al., 2013) . Deficiency in DNA repair, altered DNA methylation patterns, aberrant metabolism and reactive oxygen species, and skewed upregulation of myeloid-(at the expense of lymphoid-) associated genes all contribute to altered HSC function with age (expertly reviewed in Geiger et al., 2013) . However, in addition to intrinsic functional changes, extrinsic alterations to the HSC niche also likely to contribute toward the degeneration of HSC function with age (Woolthuis et al., 2011) .
Evidence suggests that sex steroids play at least some role in age-related degeneration of lymphopoiesis (Chinn et al., 2012) , and we, and others, have previously shown that sex steroid ablation (SSA) is able to rejuvenate aged and immunodepleted BM and thymus, enhance peripheral T and B cell function, and promote immune recovery following hematopoietic stem cell transplantation (HSCT) (Dudakov et al., 2009a; Goldberg et al., 2009; Heng et al., 2005; Sutherland et al., 2005; Velardi et al., 2014) . However, the mechanisms underlying SSA-mediated immune regeneration are still unresolved. In particular, the effects of SSA on hematopoietic stem and progenitor cells (HSPCs) are likely to be pertinent given that sex steroids regulate HSC function as well as lymphoid-primed multipotent progenitor (LMPP) cells (Medina et al., 2001; Nakada et al., 2014; Thurmond et al., 2000) . In this study, we sought to examine the events upstream of SSA-mediated lymphoid regeneration, focusing on the earliest HSPCs.
RESULTS

SSA Increases the Number of Hematopoietic Stem and Progenitor Cells
Although age-induced reduction in HSC function does not reach its nadir until at least 24 months of age in mice (Morrison et al., 1996) , it is clear that significant defects in the capacity for T and B cell differentiation are already evident by middle age (9 months) (Dudakov et al., 2009a; Heng et al., 2005; Sutherland et al., 2005) . To determine whether SSA initiates its impact early in hematopoiesis, we enumerated HSCs by flow cytometry ( Figure S1A ) at multiple time points after surgical castration of 9-month-old mice. Consistent with previous reports, there was a phenotypic increase in the absolute number of long-term HSCs (LTHSCs) during aging with a 2-fold increase by middle age ( Figure 1A ). Following SSA, there was a further increase in the absolute number of LT-HSCs and short-term HSCs (ST-HSCs) from day 14 (d14SSA), which was maintained through to d56SSA compared to sham-SSA (shSSA) control mice (Figures 1A and 1B) . While there was no observable impact of age on multipotent progenitors (MPPs), and SSA did not significantly alter their total number (Figure 1C) , there was a selective decrease in LMPPs by 9 months, which was reversed following SSA ( Figure 1D ). This change in HSC number caused by SSA was extremely long-lived with increases in FLT3
À (LT-HSC and ST-HSC) and FLT3 hi (LMPPs) still observed 1 year later ( Figure 1E ).
A defining characteristic of HSC function is the ability to differentiate into multiple lineages. The frequency of multilineage repopulating cells was therefore enumerated using a limiting-dilution competitive repopulation assay ( Figure 1F ). 10, 100, or 1,000 fluorescence-activated-cellsorted (FACS) lineage-negative, Sca1
+ , c-Kit + (LSK) cells from untreated 2-month mice; 9-month mice 7 days following sham surgery (9-month d7shSSA); or 9-month mice 7 days following surgical SSA (9-month d7SSA) were transferred along with 5 3 10 5 supporting BM cells into (E) Concatenated flow cytometry plots, gated on Lineage À cells, and absolute number of FLT3 À LSK cells, 1 year after surgical SSA of 9-month male mice (n = 5/group). (F) LSK cells were FACS purified from untreated CD45.2 + 2-month; CD45.2 + 9-month mice 7 days following surgical shSSA (d7shSSA); or CD45.2 + 9-month mice 7 days following surgical SSA (d7SSA) (n = 6 recipients/group/dose) and graded doses of cells were transferred into lethally irradiated congenic CD45.1 recipients along with 5 3 10 5 CD45.1 + supporting BM cells. Multilineage reconstitution (>1% B cell, T cell, macrophage, and granulocyte) was analyzed 12 weeks after transplant and the frequency of repopulating cells was calculated by Poisson statistics. Bar graphs represent mean ± SEM. *p < 0.05, **p < 0.01, ***p < 0.001. See also Figures S1 and S2.
lethally irradiated congenic recipients. We chose the d7SSA time point to better delineate qualitative from quantitative changes in HSCs as this was prior to any SSA-induced increase in absolute cell number ( Figure 1A ). Given there was no quantitative or functional differences in HSCs between untreated 9-month and 9-month shSSA mice (Figures 1A and S1B), all of our functional studies compared SSA mice to age-matched shSSA and untreated 2-month mice. Mice were considered reconstituted by a single HSC if there was R1% contribution of donor cells within both lymphoid (T and B cells) and myeloid (macrophage and granulocyte) lineages 12 weeks after transplant ( Figure 1F ). While there was no decrease in the frequency of multilineage repopulating cells in 9-month d7shSSA compared to 2-month mice ( Figure 1F ), functional LSK cells from 9-month d7SSA were significantly increased compared to 9-month d7shSSA controls ( Figure 1F ). When individual lineages were analyzed, mice reconstituted with 9-month d7SSA LSKs had an increased frequency of B-lineage and macrophage reconstituting cells ( Figure S1C ). All recipients, regardless of the number of cells transplanted, had detectable levels of granulocyte engraftment (data not shown), and there were no significant differences detected in T cell engraftment ( Figure S1C ). Ki67 and Annexin V (AnnV) were used to determine whether the increase in functional HSC frequency was due to a change in their cycling status or apoptosis. At day 7, there was no change in Ki67 or AnnV expression on CD34 À , CD34 + , or CD34 + CD62L + LSK subsets following SSA (Figures S1D and S1E).
SSA Significantly Enhances HSC Repopulation Potential
To assess long-term functional capacity for multilineage reconstitution, BM (2.5 3 10 6 cells) from 9-month CD45.1 + d7shSSA or d7SSA was co-transplanted at a 1:1 ratio with congenic untreated young (2 month) competitor BM into lethally irradiated 2-month CD45.2 + recipients.
Over the 17 weeks analyzed, total CD45.1 + donor-derived peripheral leukocyte reconstitution of mice transplanted with 9-month d7SSA BM was significantly higher than those reconstituted by 9-month d7shSSA mice (Figures 2A and 2B) . Reflecting this, 9-month d7SSA-derived BM significantly improved B cell engraftment, while T cell engraftment transiently increased at 4 weeks after transplant compared to 9-month d7shSSA controls ( Figure 2C ). However, enhanced reconstitution by d7SSA was not restricted to the lymphoid compartment, with a significant improvement also observed in engraftment of both monocytes/macrophages and granulocytes ( Figure 2C ). To determine the intrinsic impact on the stem and progenitor cell compartment, 2,000 purified LSK cells from untreated 2-month, 9-month d7shSSA, or 9-month d7SSA mice were co-transplanted with 2 3 10 6 BM cells from untreated congenic competitors into lethally irradiated recipients. Although there was no age-induced impact at 9-month on the ability of donor cells to engraft the BM 28 days after transplant, 9-month d7SSA-LSK significantly increased the overall number of CD45.1 + cells in the marrow ( Figure 2D) Figure 2E ).
On the other hand, long-term peripheral repopulation was significantly impaired with 9-month d7shSSA compared to untreated 2-month LSK ( Figures 2F and 2G ). Over the same time frame, there was a significant increase in the repopulation potential of LSK cells isolated from 9-month d7SSA mice, restoring the reduced middle-aged (9 month) LSK repopulation potential to 2-month levels. Increased reconstitution consisted principally of improved B cells, but also improved long-term T cell repopulation at day 135 after transplant ( Figure 2H ). Although myeloid engraftment increased with age, primarily due to granulocyte engraftment ( Figure 2H ), we found that donor LSKs from 9-month d7SSA did not further increase this engraftment above that seen in recipients of 9-month shSSA LSK cells ( Figure 2H ).
Enhanced Repopulation Ability following SSA Is Not due to Improved Homing of HSCs To assess whether improved homing of transplanted cells to the BM niche could explain our observed SSA-mediated improvements to HSC repopulation, we examined LSK cells for expression of the homing and adhesion molecules VLA-4, VLA-5, and CXCR4. Although we found a decrease in the proportion of LSK cells expressing VLA-4, VLA-5, and CXCR4 with age, there was no change in their expression following SSA (Figures S2A and S2B) , suggesting that the impacts of SSA on HSCs were intrinsic to the cells' function.
To directly examine the homing ability of LT-HSCs in vivo, we harvested BM from 9-month d7shSSA or d7SSA mice and transplanted into unablated congenic 2-or 9-month recipients at a saturating dose of 20 3 10 6 BM cell and homing and engraftment of donor LT-HSCs analyzed 40 hr later ( Figure S2C ). The same proportion of LT-HSCs homed to BM irrespective of the age of the recipient, the age of the donor, or whether donors had undergone SSA. This result also held true for downstream ST-HSCs and MPPs (data not shown). Consistent with previous studies (Dykstra et al., 2011; Liang et al., 2005) , when the number of transfused LT-HSCs was taken into account, there was a significant decrease in HSC homing in recipients of 9-month shSSA and SSA BM, as well as in aged recipients in all groups ( Figure S2D ).
HSC Self-Renewal Is Improved following SSA To assess the impact of SSA on HSC self-renewal, lethally irradiated 2-month CD45.2 mice were transplanted with 2,000 purified LSK cells from untreated 2-month, 9-month d7shSSA, or 9-month d7SSA mice together with 2.5 3 10 6 untreated congenic 2-month CD45.2 BM as support cells. 12 weeks after transplantation, 2.5 3 10 6 BM cells from primary recipients were transferred into secondary recipients along with 2.5 3 10 6 BM cells from untreated 2-month competitors. In both primary and secondary recipients, 9-month d7shSSA and untreated 2-month cells gave a similar level of donor engraftment, although with age there was a significant decline in the proportion of donorderived cells upon secondary transplant ( Figure 3A ). However, 9-month d7SSA had significantly higher levels of engraftment in both primary and secondary recipients compared to cells from 9-month d7shSSA and untreated 2-month mice. Consistent with previous reports (Dykstra et al., 2011) , there was a reduction in donor contribution between primary and secondary recipients when cells derived from 9-month d7shSSA mice were transplanted. In contrast, secondary recipients receiving 9-month d7SSA cells or 2-month cells showed no reduction in the proportion of total donor cells engrafted compared to the primary grafts ( Figure 3A ).
This defect in the reconstitution of secondary recipients was not attributable to a numerical reduction in stem cell Figure 3 . SSA Enhances the Self-Renewal Capacity of HSCs Derived from MiddleAged Mice 2,000 CD45.1 purified LSK cells from CD45.1 2-month untreated, 9-month d7shSSA, or 9-month d7SSA were transferred along with 2.5 3 10 6 untreated 2-month CD45.2 BM cells into lethally irradiated 2-month CD45.2 primary recipients (n = 6 recipients/ donor group, one individual recipient per individual donor). 12 weeks after transplant, primary recipient BM was harvested, and 2.5 3 10 6 BM cells were transplanted along with an equal dose of untreated 2-month CD45.2 BM cells into lethally irradiated 2-month CD45.2 secondary recipients (n = 12 recipient/donor groups, two recipients per individual donor). Reconstitution of secondary recipients was measured 12 weeks after transplant. (A) Proportion of CD45.1 + donor cells in BM 12 weeks following transplant in primary and secondary recipients (*Compared with 9-month d7shSSA mice within primary or secondary recipients.^Compared to untreated 2-month mice within either primary or secondary recipients. yCompared to 9-month d7shSSA between primary and secondary recipients). 6 BM cells from secondary recipients was transplanted into tertiary recipients at a 1:1 ratio with competitor CD45.2 + BM, and peripheral reconstitution was assessed at 12 weeks. Concatenated FACS plots of the proportion, and the absolute number of CD45.1 + donor cells, in tertiary recipients (n = 6/group). Results are expressed as mean ± SEM. */^p < 0.05, **/^^p < 0.01. (C and D, and G and H) 2,000 CD45.1 LT-HSCs from untreated 2-month; 9-month d7shSSA; or 9-month d7SSA were transferred into unablated 2-month Il7ra À/À recipients (n = 6 recipient/donor groups, one recipient per donor) and donor-derived hematopoiesis measured (legend continued on next page) engraftment, as there was no change in the proportion or number of donor-derived LT-HSCs in the BM of secondary recipients as a consequence of age or SSA ( Figures 3B and  3C ). However, consistent with the functional decline in lymphopoiesis with age, there was a significant decrease in donor-derived LMPPs from 9-month d7shSSA, which was reversed in secondary recipients of 9-month d7SSA cells ( Figures 3B and 3C ). Within specific hematopoietic lineages, although there was no loss in the proportion of donor-derived T cells or CD11b + myeloid cells with age,
there was a decline in B cell reconstitution, which contributed toward a global decline in CD45 + cells ( Figures   3D and 3E ). Importantly, secondary reconstitution from 9-month d7SSA BM significantly increased the donor contribution of all leukocyte subsets ( Figures 3D and 3E ), but this effect of SSA on HSC self-renewal was finite as there was no difference in donor contribution between 9-month d7shSSA and 9-month d7SSA in tertiary recipients ( Figure 3F ).
SSA Increased the Lymphoid Differentiation Capacity of LT-HSCs
The dominant downstream effects of SSA in steady-state aged mice are on lymphopoiesis, with little if any impact observed on myeloid cells. To test the lymphoid differentiation capacity of the BM as a whole, we transferred 5 3 10 6 BM cells derived from 2-month, 9-month d7shSSA, or 9-month d7SSA mice into unirradiated Il7ra À/À recipients, which bypasses the confounding effects of total body irradiation (TBI) (Gossens et al., 2009 ). We found a significant defect by 9 months in the ability of BM to engraft IL7Ra À/À recipients. As expected, this was predominantly composed of declines in donorderived TCRb + T cells and B220 + B cells (Figures 4A and 4B) . To test the relative functional changes between HSCs and their downstream progenitors, we transferred 2,000 LT-HSCs or LMPPs derived from untreated 2-month, 9-month d7shSSA, or 9-month d7SSA mice into unirradiated Il7ra À/À recipients. LT-HSCs isolated from 9-month d7shSSA mice exhibited reduced engraftment at day 70 compared to untreated 2-month LT-HSCs in both B and T cell lineages. However, Il7ra À/À recipients transplanted with 9-month d7SSA cells restored the differentiation capacity of aged LT-HSCs to that of untreated 2-month ( Figures 4C and 4D ). Interestingly, although we found a significant decline in their differentiation capacity with age, there was little effect of SSA on lymphoid differentiation of LMPPs on a per-cell basis ( Figures 4E and 4F) . Thus, increased lymphopoiesis seems to be predicated wholly on the intrinsic increase in HSC function. Given that Il7ra À/À mice have a selective deficiency in lymphopoiesis, we would only expect limited myeloid engraftment, and indeed that was the case when we transplanted whole bone marrow (WBM) ( Figures S3A and S3B ). However, interestingly, when LT-HSCs were transplanted, although there was no change in engraftment of granulocytes either as a consequence of age or SSA ( Figure 4G ), there was a significant decrease in monocyte/macrophage reconstitution with age, which was reversed after SSA ( Figure 4H ).
Early Intrinsic Functional Changes in LT-HSCs
To identify whether any functional effects could be observed in HSCs earlier than day 7, 8,000-10,000 CD34-FLT3 À LT-HSCs from 9-month d2SSA mice, 9-month d7SSA mice, or their shSSA controls were co-cultured with OP9-DL1 cells for 12 days. Consistent with our in vivo data, LT-HSCs derived from 9-month SSA mice progressed more rapidly to the DN2 and DN3 stages of T cell development when compared to LT-HSCs isolated from 9-month shSSA mice ( Figure 5A ). To explore the intrinsic mechanistic changes to the stem cell compartment after SSA, we performed transcriptome analysis on LT-HSCs from 9-month shSSA and 9-month SSA mice, 2 days after surgery. 251 genes were significantly altered (p < 0.05; >1.5-fold change), 55 upregulated and 196 downregulated ( Figure 5B ). Core pathway analysis revealed 24 genes upregulated and 13 downregulated in d7SSA LT-HSCs under the ''Hematological System Development and Function'' pathway (Table S1 ), indicating that even using an unbiased approach revealed hematopoietic-related gene changes. + monocyte/ macrophages. Results are expressed as mean ± SEM. *p < 0.05, **p < 0.01, ***p < 0.001. See also Figure S3 .
could be broadly grouped into those that impacted on cell cycle and cell differentiation ( Figures 5C and 5D) , including downregulation of cell-cycle inhibitors such as ARF proteins Nkx3-1, Dkk1, and Cebpa and pro-apoptotic factors including Cebpe, Prg3, and Nlrp10. There was also an upregulation of genes promoting proliferation such as Foxq1, Hoxb7, Zfhx1a, and Fgfbp3. Consistent with the marked shift in lineage differentiation potential of HSCs with age, previous studies have found considerable gene usage skewing in HSCs from old mice away from lymphoid-associated and toward myeloid-associated genes (Rossi et al., 2005) . We found that as early as day 2 after SSA, there was a significant decrease in genes associated with myeloid differentiation (Prg2, Ela2, Mpo, and Ear-2, -4) as well as upregulation of genes previously associated with lymphopoiesis (Zbtb7a, Rag1ap1, Tbx1, and Tcta) ( Figure 5D ).
SSA Alters Intrinsic Gene Expression by Hematopoietic Niche Cells
Given the intimate relationship between HSCs and their microenvironment, we performed transcriptome analysis on non-hematopoietic cells from the sinusoidal niche of 2-and 9-month untreated mice, 9-month shSSA, and 9-month SSA mice at days 2, 4, 7, and 10 post-SSA. 160 genes were downregulated and 72 upregulated (>2-fold) between untreated 2-and 9-month mice ( Figure S4A ). Of the 160 downregulated genes, pattern discovery (correlation >0.7) revealed 116 that became progressively more similar after SSA to untreated 2-month mice ( Figure 6A ; Table S2 ). Genes of note following this pattern included Spib, which can be induced by RANKL, a factor critical for osteoblast (OBL) differentiation (de Lau et al., 2012; Wilson, 2011) Figure 5 . Intrinsic Molecular Changes within HSCs after SSA (A) 10,000 LT-HSCs from 9-month shSSA or 9-month SSA mice 2 or 7 days after surgery were plated onto OP9-DL1 cells and T cell differentiation assessed at day 12. Concatenated FACS plots gated on CD4
LT-HSCs from 9-month d2shSSA or 9-month d2SSA mice were FACS purified, and transcriptome analysis was performed (n = 3 biological replicates, where each replicate included cells pooled from 10-20 animals). (B) Volcano plot outlining gene expression between 9-month d2shSSA and 9-month d2SSA LT-HSCs. 251 genes were significantly altered (p < 0.05; >1.5-fold change), 55 upregulated and 196 downregulated. (C and D) Significant changes between 9-month d2shSSA and 9-month d2SSA LT-HSCs in genes involved with cellcycle regulation (C) or differentiation (D).
has been implicated in protection from age-associated pathologies in other tissues (van der Horst and Burgering, 2007). qPCR of highly purified niche subsets confirmed an increase in Foxo1 expression by pre-OBLs as early as day 2 after SSA ( Figure 6B ). Gene ontology analysis of the 116-gene cluster revealed 50 Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways ( Figure S4B ), including (1) gap junction molecules, which have been found to regulate hematopoiesis and prevent HSC senescence (Schajnovitz et al., 2011; Taniguchi Ishikawa et al., 2012) , (2) cell adhesion molecule-associated pathways, which modulate the interaction of HSCs with their stromal niche (Mendelson and Frenette, 2014) , and (3) the MAPK signaling pathway, which regulates the balance between HSC expansion, survival, and differentiation and has also been implicated in promoting thymopoiesis (Geest and Coffer, 2009 (Pinho et al., 2013) . Analysis revealed no significant changes in niche population size with age or SSA (data not shown). Although there was no notable difference in endothelial gene expression at d2SSA (9 month), there was a significant increase in the expression of Kitlg and Il7 by day 7 ( Figure 6C ), both of which could aid in lymphoid differentiation. Within the pre-OBL population, there was a large early transient increase in Scf expression and Angiopoietin-1 (Ang-1) at day 2, which subsided by day 7 ( Figure 6D ). Despite sinusoidal niche-residing preOBLs expressing a fraction of the Opn compared to endosteal OBLs on a per-cell basis ( Figure S4C ), 7 days following SSA sinusoidal pre-OBLs showed a 30-fold increase in Opn production compared to shSSA control mice. Within the mature endosteal OBL population, there was an initial decline in the expression of Cxcl12, Scf, Angpt1, Bmp4, and Il7 at day 2. However, by day 7 there was a significant increase in many of these factors including Spp1, Ang1, Cxcl12, Kitlg, Jag1, Vcam1, Bmp4, and Tgfb as well as decreased Igf1 ( Figure 6E ). 
TER119
À cells from 2-and 9-month untreated mice, 9-month shSSA control, and 9-month SSA mice at days 2, 4, 7, and 10 after surgery (n = 1, ten mice pooled/sample). (A) Pattern discovery (correlation >0.7) identified 132 probes that demonstrated an increasing gene expression trend toward young profiles following castration of middle-aged mice. (B) qPCR of Foxo1 expression in pre-OBLs purified from untreated 2-or 9-month mice, and 9-month d2shSSA or 9-month d2SSA mice. (C-E) Expression of Cxcl12, Kitlg, Spp1, Ang1, Jag1, Vcam1, Bmp4, Il7, Tgfb, and Igf1 in endothelial cells (C), pre-OBLs (D), and OBLs (E) from 9-month d2SSA and 9-month d7SSA. Expression is represented as 9-month d7SSA relative to 9-month d7shSSA control mice, n = 3-11 independent experiments. *p < 0.05, **p < 0.01, ***p < 0.001. See also Figure S4 .
SSA Mediates Regeneration of the Hematopoietic Niche to Promote Lymphopoiesis
Consistent with these molecular changes in niche function, 9-month SSA-treated recipients of untreated 2-month HSCT had significantly greater engraftment of LSK cells compared with 9-month shSSA control recipients, even with ten times fewer cells transplanted (Figures 7A and 7B) . This engraftment was reflected in the periphery at 4 and 12 weeks after transplant where there was an increased total number of donor cells ( Figures 7C and 7D) . In addition, the number of donor T cells, B cells, and macrophages was also significantly increased in recipients that had been given SSA regardless of which dose of cells they were given ( Figure 7E ). However, interestingly, within the granulocyte population we could detect no difference in engraftment in mice regardless of their SSA status or cell dose infused (Figure 7E) . This suggests that, in addition to enhancing HSC function, SSA also enhances the function of the niche and its ability to support hematopoiesis.
DISCUSSION
One of the hallmarks of aging is reduced generation of new lymphocytes. Although there is a profound decline in the number of lymphoid progenitors with age (Min et al., 2004 (Min et al., , 2006 ) that can be reversed by SSA, consistent with their sensitivity to sex steroids (Medina et al., 2001) , we have demonstrated here and in previous work that the function of lymphoid progenitors does not change on a per-cell basis after SSA . Rather, upstream HSCs exhibit improved overall function early after the cessation of testosterone production. One hypothesis that may explain this early functional shift would be an immediate and direct intrinsic impact on stem and progenitor cells due to the removal of the negative influences of sex steroids. This was supported by the early molecular and functional changes within a highly purified population of LT-HSCs 2 days after SSA. Noteworthy among the altered genes in LT-HSCs post-SSA were downregulation of Dkk1, a wnt inhibitor that can be upregulated by androgens and mediate aging degeneration (Kwack et al., 2008; Seib et al., 2013) ; decreased Erbb3, elevated levels of which correlate with androgen-responsive prostate cancers (Koumakpayi et al., 2006) ; increased expression of Efna1, which has been implicated in enhanced proliferation and is downregulated upon exposure to androgens (Nantermet et al., 2004) ; decreased Arf3 and Arf4, which have been implicated in regulating CDC42 (Erickson et al., 1996) , a potential mediator of HSC aging and regeneration (Florian et al., 2012) ; upregulation of genes directly involved with lymphoid differentiation, such as Zbtb7a, Tbx1, and Rag1ap1 (Gennery, 2012; Maeda et al., 2007) ; and downregulation of Ear2, which has recently been described as a negative regulator of T cell development (Ichim et al., 2014) .
In our previous studies, we demonstrated that after SSA there is a significant increase in the number of all developing B and T cell subsets (Dudakov et al., 2009a (Dudakov et al., , 2009b Goldberg et al., 2010; Heng et al., 2005; Sutherland et al., 2005) . However, in this study there was a clear increase in B lymphopoiesis, while thymopoiesis was only sometimes increased. Both T and B lymphopoiesis occur in very close contact with their respective stromal microenvironments; however, T cell development is entirely dependent on these interactions, while some B lymphopoiesis can be achieved independently of the BM stromal microenvironment (Carsetti, 2000; Nagasawa, 2006; Takahama, 2006) . Therefore, one hypothesis could be that altering the intrinsic function of HSCs-although enough to profoundly impact on B lymphopoiesis-is not sufficient to promote thymopoiesis, which may require additional stimulation of the stromal microenvironment. Consistent with this hypothesis, increases after SSA in T-lineage progenitors such as LMPP and CLP were not by themselves enough to promote increased thymopoiesis, without additional impact on the thymic stromal microenvironment. In addition to intrinsic changes in HSCs, we also found a qualitative change to the BM niche, which likely contributes to the improved function of HSCs after SSA. Consistent with this, we have previously found that SSA can significantly improve hematopoietic reconstitution after HSCT (Goldberg et al., , 2007 (Goldberg et al., , 2009 , and here we could demonstrate that fewer cells were needed for effective engraftment. There is some rationale for these findings, as (1) exposure of aged satellite stem cells to a young microenvironment reverses their age-related changes (Conboy et al., 2005) , and (2) subsequently several studies have reported that circulating factors in young mice can reverse age-related defects in a number of tissues including heart, brain, and skeletal muscle (Loffredo et al., 2013; Sinha et al., 2014; Villeda et al., 2014) . Pattern analysis of the changed genes within the stromal microenvironment revealed a distinct shift in gene expression after SSA from a profile characteristic of an aged mouse to that of the young by d10 after SSA. Of particular interest within this group was the gene Foxo1, which has been described in the development and differentiation of OBLs, regulating their expression of Runx2 and Bglap (Teixeira et al., 2010; Yang et al., 2011) , and preventing differentiation of mesenchymal progenitor cells into fat or muscle (Nakae et al., 2003) . Foxo1 has also been implicated with protection during aging (van der Horst and Burgering, 2007) , with Foxo1-deficient mice displaying aberrant hematopoietic phenotypes resembling those seen with age; however, it is unclear whether these are intrinsic to HSCs or mediated through the BM microenvironment Tothova et al., 2007) . Consistent with these changes after SSA, the androgen receptor can directly bind the Foxo1 promoter and regulate its action, and FOXO1 can inhibit androgen receptor transcription (Liu et al., 2008; Ma et al., 2009 ). In addition, IGF-1, expression of which is almost completely abrogated after SSA, triggers the inactivation of FOXO1 by nuclear exclusion (Yang et al., 2011) .
Analysis of known hematopoietic niche interactions (Mercier et al., 2012) revealed upregulation following SSA of Spp1, Ang1, Cxcl12, Kitlg (Scf), Tgfb, Jag1, and Vcam1-many of which can be directly regulated by FOXO1 (Ferdous et al., 2011; Martinez et al., 2008; Potente et al., 2005) .
Taken together, these data indicate that the widespread downstream impacts of SSA on lymphopoiesis are at least partially attributable to the considerable effects on primitive HSC function, thereby demonstrating mechanisms by which lymphopoiesis can be rejuvenated following SSA. Given that SSA can be achieved clinically, and reversibly, using currently approved agonists and antagonists of the sex steroid pathway (e.g., LHRH/GnRH), and that these improve immune function (Goldberg et al., 2009; Velardi et al., 2014) , it has important implications for replenishing the diminished repertoire of lymphoid cells following damaging cytoablative treatments associated with bone marrow transplantation and cancer therapies. While the capacity for long-term BM regeneration following SSA has not yet been established, this work provides the basis for more detailed investigations into hematopoietic niche aging and SSA-induced rejuvenation, to develop more targeted strategies for HSC recovery.
EXPERIMENTAL PROCEDURES
Animals
Young (2 months) or middle-aged (9 months) male C57Bl/6 or Ly5.1 mice were obtained from the Animal Resources Centre or Monash Animal Services. Il7ra À/À mice were kindly provided by A. Strasser (Walter and Eliza Hall Institute, Melbourne). All animal experimentation was carried out at Monash University in accordance with animal experiment ethics committee guidelines. Surgical removal of the testes was performed on male mice as previously described . Recipient mice were lethally irradiated with 1,100-cGy total body irradiation ( 137 Cs source) as a split dose (2 3 550 cGy) separated by 3 hr and provided with antibiotics (Baytril) in water for 2 weeks after transplantation.
Cell Isolation and Analysis
Cell suspensions of the sinusoidal compartment were obtained by flushing tibias and femurs. Absolute numbers were calculated based on the total numbers of viable nucleated cells harvested from two tibias and two femurs. Osteoblasts from the endosteal niche were isolated by crushing flushed bones and digesting with 0.3% (w/v) Collagenase/Dispase (Roche) and 0.1% (w/v) DNase I (Roche) in RPMI-1640. Flow cytometric analysis and sorting was performed on FACSCalibur, FACSCanto II, FACSVantage, FACSAria, or Influx (BD Biosciences) cytometers and cell sorters. Gates were typically set using appropriate isotype controls.
Microarray and qPCR Analysis
Microarrays and bioinformatics were performed at the Australian Genome Research Facility (AGRF) using Partek v.6.5. Pathway.
Analysis on LT-HSCs was conducted using Ingenuity Pathway Analysis (IPA) software. qPCR was performed using Platinum SYBR Green Supermix-UDG (Invitrogen) on a Corbett RotorGene 3000 (Corbett Research). Relative levels of target mRNA was compared to GAPDH using the 2 ÀDDCt method, comparing 9-month d7SSA mice to 9-month d7shSSA control mice.
Statistical Analysis
Statistical analysis was performed using nonparametric, unpaired Mann-Whitney U test. Limiting dilution CRU frequencies were calculated by L-calc software (STEMCELL Technologies), using Poisson statistics (two-tailed test). Comparative analysis of relative gene expression in SSA mice was performed using Student's t test.
ACCESSION NUMBERS
The NCBI GEO accession number for gene expression data reported in this paper is GSE64841. 
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Microarray and qPCR analysis
Isolated RNA was amplified from purified cell populations (>99%) using the Ambion Total Prep Amplification kit and hybridized to Illumina Mouse WG-6_V2
(LT-HSCs) arrays or Affymetrix arrays (non-hematopoietic niche cells). Pre-
Tgfb1 (QT00145250); and Igf1 (QT00154469) were purchased from Qiagen.
Figure S1 (B). 5 x 10 6 BM cells from untreated 9mo mice or 9mo mice that had undergone shSSA 7 days earlier were transplanted along with 5 x 10 6 BM cells from untreated 2mo mice into lethally irradiated (2 x 550cGy) congenic recipients. 
